Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr
News

Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr

The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023

  • By IPP Bureau | May 12, 2023

Bliss GVS Pharma Limited has posted net profit Rs. 3.34 crores for the period ended March 31, 2023 as against net profit of Rs. 27.94 crores for the period ended December 31, 2022. The company posted net profit of Rs.19.63 crores for the period ended March 31, 2022.

The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023 as compared to Rs. 211.36 crores during the period ended December 31, 2022. It reported total income of Rs.179.25 crores during the period ended March 31, 2022.

For the Financial Year ended March 31, 2023, Bliss GVS Pharma has reported total income of Rs.769.37 crores as compared to Rs.778.94 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.70.85 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.15.04 crores for the Financial Year ended March 31, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization